Asokan Devarajan
Impact in
- Clinical Biochemistry top 1%
- Paraoxonase enzyme and polymorphisms
- Biochemistry top 5%
- Biochemical Acid Research Studies
Papers in
-
- Coenzyme Q10 studies and effects 4
- Genomics, phytochemicals, and oxidative stress 4
-
- Paraoxonase enzyme and polymorphisms 14
- Co-authors
- Srinivasa T. Reddy (15 shared papers)Víctor Grijalva (8 shared papers)Diana M. Shih (5 shared papers)Noam Bourquard (6 shared papers)Shukkur M. Farooq (6 shared papers)Namakkal S. Rajasekaran (7 shared papers)Palaninathan Varalakshmi (6 shared papers)Alan M. Fogelman (4 shared papers)
- Journals
- Redox Biology (5 papers)Free Radical Biology and Medicine (3 papers)Molecular Genetics and Metabolism (2 papers)Frontiers in Cardiovascular Medicine (2 papers)Scientific Reports (1 paper)
- Partner nations
- United StatesIndiaMalaysia
In The Last Decade
Asokan Devarajan
36 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 105
- Clinical Biochemistry 372
- Biochemistry 92
- Complementary and Manual Therapy 24
- Pharmacology 126
- Pharmacology 56
Countries citing papers authored by Asokan Devarajan
This map shows the geographic impact of Asokan Devarajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asokan Devarajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asokan Devarajan more than expected).
Fields of papers citing papers by Asokan Devarajan
This network shows the impact of papers produced by Asokan Devarajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asokan Devarajan. The network helps show where Asokan Devarajan may publish in the future.
Co-authors
The 25 scholars most cited alongside Asokan Devarajan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 150 | |
| 2 | 2012 | 71 | |
| 3 | 2012 | 71 | |
| 4 | 2019 | 68 | |
| 5 | 2011 | 57 | |
| 6 | 2014 | 52 | |
| 7 | 2019 | 51 | |
| 8 | 2014 | 48 | |
| 9 | 2008 | 48 | |
| 10 | 2014 | 42 | |
| 11 | 2004 | 38 | |
| 12 | 2018 | 37 | |
| 13 | 2020 | 36 | |
| 14 | 2014 | 35 | |
| 15 | 2016 | 34 | |
| 16 | 2004 | 33 | |
| 17 | 2013 | 32 | |
| 18 | 2012 | 28 | |
| 19 | 2018 | 27 | |
| 20 | 2019 | 26 |
About Asokan Devarajan
Asokan Devarajan is a scholar working on Molecular Biology, Clinical Biochemistry, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Paraoxonase enzyme and polymorphisms (14 papers), Kidney Stones and Urolithiasis Treatments (8 papers), Apelin-related biomedical research (5 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Coenzyme Q10 studies and effects (4 papers), Genomics, phytochemicals, and oxidative stress (4 papers), Heart Rate Variability and Autonomic Control (3 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). The work is most often cited by research in Clinical Biochemistry (372 citations), Biochemistry (92 citations), Complementary and Manual Therapy (24 citations), Pharmacology (126 citations) and Pharmacology (56 citations). Asokan Devarajan has collaborated with scholars based in United States, India and Malaysia. Frequent co-authors include Srinivasa T. Reddy, Víctor Grijalva, Diana M. Shih, Noam Bourquard, Shukkur M. Farooq, Namakkal S. Rajasekaran, Palaninathan Varalakshmi, Alan M. Fogelman, Periandavan Kalaiselvi and Ines Witte. Their work appears in journals such as Redox Biology, Free Radical Biology and Medicine, Molecular Genetics and Metabolism, Frontiers in Cardiovascular Medicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.